Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
Report Offers Comprehensive Look at Global Smokeless Tobacco UseThe first report of its kind finds that more than 300 million people worldwide use smokeless tobacco products and that they are linked to a number of cancers.
-
New on Cancer.gov: Resources on Melanoma TherapiesSeveral new resources that provide more details about the changing treatment landscape for advanced melanoma have recently been added to Cancer.gov.
-
Which Patients Will Benefit from Immunotherapy for Cancer? Some Hints EmergeResearchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders to this treatment as well as for developing new treatments.
-
Method for Identifying Combination Therapies to Combat Treatment Resistance Shows PromiseResearchers from the Massachusetts General Hospital Cancer Center in Boston have reported on a method for studying treatment resistance that may identify combinations of targeted therapies that can help to combat resistance in some patients.
-
Debate, Research on E-Cigarettes ContinueSince they first began to be sold in North America in the mid-2000s, electronic cigarettes have been the subject of intense debate. NCI's Dr. Michele Bloch recently presented an update on some of the issues surrounding e-cigarettes.
-
Building on Opportunities in Cancer Research: NCI’s Annual Plan and Budget Proposal for FY 2016NCI’s Director, Dr. Harold Varmus, introduces the NCI Annual Plan and Budget Proposal for Fiscal Year 2016.
-
Human Papillomavirus (HPV) Vaccines: An Interview with Douglas R. Lowy, M.D.NCI’s Dr. Doug Lowy discusses HPV vaccines, including their efficacy, safety, and the development of next-generation vaccines.